[Effects of bezafibrate in patients with combined hyperlipidemia]. 1986

R Vílchez Joya, and F Escobar Jiménez, and M M Campos, and E Torres, and R Orduña, and J Cabrera, and J Núñez

UI MeSH Term Description Entries
D006950 Hyperlipidemia, Familial Combined A type of familial lipid metabolism disorder characterized by a variable pattern of elevated plasma CHOLESTEROL and/or TRIGLYCERIDES. Multiple genes on different chromosomes may be involved, such as the major late transcription factor (UPSTREAM STIMULATORY FACTORS) on CHROMOSOME 1. Hyperlipidemia, Multiple Lipoprotein-Type,Familial Combined Hyperlipidemia,Combined Hyperlipidemia, Familial,Combined Hyperlipidemias, Familial,Familial Combined Hyperlipidemias,Hyperlipidemia, Multiple Lipoprotein Type,Hyperlipidemias, Familial Combined,Hyperlipidemias, Multiple Lipoprotein-Type,Lipoprotein-Type Hyperlipidemia, Multiple,Lipoprotein-Type Hyperlipidemias, Multiple,Multiple Lipoprotein-Type Hyperlipidemia,Multiple Lipoprotein-Type Hyperlipidemias
D008297 Male Males
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D003924 Diabetes Mellitus, Type 2 A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. Diabetes Mellitus, Adult-Onset,Diabetes Mellitus, Ketosis-Resistant,Diabetes Mellitus, Maturity-Onset,Diabetes Mellitus, Non-Insulin-Dependent,Diabetes Mellitus, Slow-Onset,Diabetes Mellitus, Stable,MODY,Maturity-Onset Diabetes Mellitus,NIDDM,Diabetes Mellitus, Non Insulin Dependent,Diabetes Mellitus, Noninsulin Dependent,Diabetes Mellitus, Noninsulin-Dependent,Diabetes Mellitus, Type II,Maturity-Onset Diabetes,Noninsulin-Dependent Diabetes Mellitus,Type 2 Diabetes,Type 2 Diabetes Mellitus,Adult-Onset Diabetes Mellitus,Diabetes Mellitus, Adult Onset,Diabetes Mellitus, Ketosis Resistant,Diabetes Mellitus, Maturity Onset,Diabetes Mellitus, Slow Onset,Diabetes, Maturity-Onset,Diabetes, Type 2,Ketosis-Resistant Diabetes Mellitus,Maturity Onset Diabetes,Maturity Onset Diabetes Mellitus,Non-Insulin-Dependent Diabetes Mellitus,Noninsulin Dependent Diabetes Mellitus,Slow-Onset Diabetes Mellitus,Stable Diabetes Mellitus
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001161 Arteriosclerosis Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries. Arterioscleroses
D001629 Bezafibrate An antilipemic agent that lowers CHOLESTEROL and TRIGLYCERIDES. It decreases LOW DENSITY LIPOPROTEINS and increases HIGH DENSITY LIPOPROTEINS. Azufibrat,BM-15.075,Befibrat,Beza-Lande,Beza-Puren,Bezabeta,Bezacur,Bezafibrat PB,Bezafisal,Bezalip,Bezamerck,Béfizal,Cedur,Difaterol,Eulitop,Lipox,Reducterol,Regadrin B,Sklerofibrat,Solibay,durabezur,BM 15.075,BM15.075,Beza Lande,Beza Puren
D014280 Triglycerides An ester formed from GLYCEROL and three fatty acid groups. Triacylglycerol,Triacylglycerols,Triglyceride

Related Publications

R Vílchez Joya, and F Escobar Jiménez, and M M Campos, and E Torres, and R Orduña, and J Cabrera, and J Núñez
May 1983, Casopis lekaru ceskych,
R Vílchez Joya, and F Escobar Jiménez, and M M Campos, and E Torres, and R Orduña, and J Cabrera, and J Núñez
December 1992, Clinical pharmacology and therapeutics,
R Vílchez Joya, and F Escobar Jiménez, and M M Campos, and E Torres, and R Orduña, and J Cabrera, and J Núñez
December 1986, Harefuah,
R Vílchez Joya, and F Escobar Jiménez, and M M Campos, and E Torres, and R Orduña, and J Cabrera, and J Núñez
May 2017, Journal of veterinary internal medicine,
R Vílchez Joya, and F Escobar Jiménez, and M M Campos, and E Torres, and R Orduña, and J Cabrera, and J Núñez
January 1993, Clinical therapeutics,
R Vílchez Joya, and F Escobar Jiménez, and M M Campos, and E Torres, and R Orduña, and J Cabrera, and J Núñez
July 1986, Journal of lipid research,
R Vílchez Joya, and F Escobar Jiménez, and M M Campos, and E Torres, and R Orduña, and J Cabrera, and J Núñez
February 1989, Boletin de la Asociacion Medica de Puerto Rico,
R Vílchez Joya, and F Escobar Jiménez, and M M Campos, and E Torres, and R Orduña, and J Cabrera, and J Núñez
December 2002, Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego,
R Vílchez Joya, and F Escobar Jiménez, and M M Campos, and E Torres, and R Orduña, and J Cabrera, and J Núñez
September 1988, Nihon yakurigaku zasshi. Folia pharmacologica Japonica,
R Vílchez Joya, and F Escobar Jiménez, and M M Campos, and E Torres, and R Orduña, and J Cabrera, and J Núñez
February 1983, Deutsche medizinische Wochenschrift (1946),
Copied contents to your clipboard!